Mirzotamab, CAS [[2229859-11-2]]

Produktübersicht

• Artikelname: Mirzotamab, CAS [[2229859-11-2]]
• Artikelnummer: MCE-HY-P99740
• Hersteller Artikelnummer: HY-P99740
• Alternativnummer: MCE-HY-P99740-1MG,MCE-HY-P99740-5MG,MCE-HY-P99740-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper

Produktbeschreibung

Mirzotamab is an IgG1kappa monoclonal antibody targeting to CD276/B7-H3 with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC)[1][2][3].

Produkteigenschaften

• Molekulargewicht: (144.86 kDa)
• Reinheit: 99.45
• CAS Nummer: [2229859-11-2]
• Target-Kategorie: ADC Antibody,CD276/B7-H3

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies